Forum for Science, Industry and Business
Sponsored by:     Siemens  n-tv 
Search our Site:

Topic (optional):

 

Home Reports Health and Medicine Content

Bronchiolitis – best practice summed up

next article
19.12.2006

An “umbrella review” published in the latest edition of Evidence-Based Child Health: A Cochrane Review Journal neatly summaries the evidence base for the various treatment options for bronchiolitis. The review highlights the lack of treatment for a frequently experienced illness, and points to the urgent need for research.

 

What is bronchiolitis?


Bronchiolitis is the most common severe lower respiratory infection in infants. It occurs when a viral infection causes infants’ lower airways to become inflamed. They have difficulty breathing, sleeping and feeding.

What is its incidence?

Bronchiolitis affects 10-20% of infants under the age of two. Three percent of these are admitted to hospital, meaning that around 1.8 million infants are taken to US hospitals each year. Of these, 2.7% need intensive care, 1.5% need ventilation and 0.2% die.

Clinical comment

If there is no respiratory distress, feeding difficulties or specific risk factors, the infant can be treated at home with advice on when to return for re-assessment. If there are respiratory problems infants should be hospitalized and clinical treatment is normally limited to ensuring the infant is given adequate fluids, and oxygen. This can allow time for the infant to recover. Nebulised epinephrine may produce marginal relief, and could help some infants go home. The effect, however, is mild.

Various treatments have been tried in patients who are more severely affected, but none produce any marked effects. Bronchodilators and epinephrine produce no benefits, though some people suggest they may reduce restlessness and sleeplessness. Similarly, neither injecting steroids or immunoglobulins, nor giving vibration or percussive physiotherapy reduces symptoms.

A clear need for research

“What we need is a large randomised trial that carefully studies all of the currently available therapies and sees whether adjusting dose, type or frequency of treatment can produce greater benefit – then we need to examine new-comers,” says Dr. Michael Smith, author of the review, who works in the Department of Paediatrics, Craigavon Area Group Hospital Trust, Craigavon, Northern Ireland.

Evidence-Based Child Health: A Cochrane Review Journal is available online via Wiley InterScience, the online content service at: www.evidence-basedchildhealth.com

Polly Young | Source: alphagalileo
Further information: www.evidence-basedchildhealth.com

next article

More articles from Health and Medicine:

nachricht Polyphenols and polyunsaturated fatty acids boost the birth of new neurons
25.11.2009 | Universitat Autonoma de Barcelona

nachricht Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps
24.11.2009 | Johns Hopkins Medical Institutions

All articles from Health and Medicine >>>

B2B Search

Product / Service
Company / Organisation

Latest News

First black holes may have incubated in giant, starlike cocoons

25.11.2009 | Physics and Astronomy

KfW issues its first ever 7 year Euro-Benchmark

25.11.2009 | Business and Finance

Intelligence inside metal components

25.11.2009 | Information Technology

VideoLinks
More VideoLinks >>>

Event News

Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients

20.11.2009 | Event News

'Golden Age' for clinical psychology in Northern Ireland

20.11.2009 | Event News

New Perspectives in Marine Anti-Fouling Research

11.11.2009 | Event News